Genenta Science (GNTA)

• Market cap: $17.3M
• 1 day: -0.79%
• 5 days: -29.62%
• 1 month: -48.81%
• 3 months: -68.03%
• 6 months: -80.74%
• Year to date: -48.09%
• 1 year: -81.42%
• 5 years: -93.35%
• 10 years: -93.35%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 13